1. Home
  2. VERU vs TRX Comparison

VERU vs TRX Comparison

Compare VERU & TRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • TRX
  • Stock Information
  • Founded
  • VERU 1971
  • TRX 1990
  • Country
  • VERU United States
  • TRX Canada
  • Employees
  • VERU N/A
  • TRX N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • TRX
  • Sector
  • VERU Health Care
  • TRX
  • Exchange
  • VERU Nasdaq
  • TRX Nasdaq
  • Market Cap
  • VERU 85.5M
  • TRX 95.9M
  • IPO Year
  • VERU 1990
  • TRX N/A
  • Fundamental
  • Price
  • VERU $0.49
  • TRX $0.35
  • Analyst Decision
  • VERU Strong Buy
  • TRX Strong Buy
  • Analyst Count
  • VERU 2
  • TRX 1
  • Target Price
  • VERU $4.00
  • TRX $1.10
  • AVG Volume (30 Days)
  • VERU 1.4M
  • TRX 602.2K
  • Earning Date
  • VERU 08-07-2025
  • TRX 07-15-2025
  • Dividend Yield
  • VERU N/A
  • TRX N/A
  • EPS Growth
  • VERU N/A
  • TRX N/A
  • EPS
  • VERU N/A
  • TRX N/A
  • Revenue
  • VERU $16,886,419.00
  • TRX $47,731,000.00
  • Revenue This Year
  • VERU N/A
  • TRX $51.45
  • Revenue Next Year
  • VERU N/A
  • TRX $26.19
  • P/E Ratio
  • VERU N/A
  • TRX $333.29
  • Revenue Growth
  • VERU 134.43
  • TRX 29.98
  • 52 Week Low
  • VERU $0.45
  • TRX $0.27
  • 52 Week High
  • VERU $1.42
  • TRX $0.43
  • Technical
  • Relative Strength Index (RSI)
  • VERU 34.85
  • TRX 50.08
  • Support Level
  • VERU $0.57
  • TRX $0.34
  • Resistance Level
  • VERU $0.61
  • TRX $0.35
  • Average True Range (ATR)
  • VERU 0.04
  • TRX 0.02
  • MACD
  • VERU -0.01
  • TRX 0.00
  • Stochastic Oscillator
  • VERU 0.13
  • TRX 33.20

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.

About TRX TRX Gold Corporation

TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.

Share on Social Networks: